These results indicate TGFβ as a potential marker of fibrotic and vascular involvement in SSc on one side, and on the other side, it reflects an altered microenvironment, which may predispose circulating monocytes towards an activated and profibrotic phenotype. Here, TGFB1 is linked to systemic sclerosis.